Valuation: Vivos Therapeutics, Inc.

Market Cap 6.13M 5.39M 4.96M 4.64M 8.7M 579M 8.86M 59.55M 23.07M 285M 23.03M 22.53M 991M P/E 2026 *
-0.24x
P/E 2027 * -0.53x
Enterprise Value 6.13M 5.39M 4.96M 4.64M 8.7M 579M 8.86M 59.55M 23.07M 285M 23.03M 22.53M 991M EV / Sales 2026 *
0.27x
EV / Sales 2027 * 0.18x
Free-Float
74.28%
Yield 2026 *
-
Yield 2027 * -
1 day+0.82%
1 week-11.74%
Current month-36.96%
1 month-31.76%
3 months-61.29%
6 months-78.26%
Current year-78.26%
1 week 0.38
Extreme 0.383
0.5
1 month 0.38
Extreme 0.383
1.36
Current year 0.38
Extreme 0.383
2.69
1 year 0.38
Extreme 0.383
7.95
3 years 0.38
Extreme 0.383
48.79
5 years 0.38
Extreme 0.383
177.25
10 years 0.38
Extreme 0.383
360.25
Manager TitleAgeSince
Chief Tech/Sci/R&D Officer - -
Chief Operating Officer - 2016-08-31
Chief Executive Officer 68 2016-08-31
Director TitleAgeSince
Director/Board Member 61 2016-04-30
Director/Board Member 69 2020-05-31
Director/Board Member 63 2020-05-31
Date Insider Type Main position Quantity % Market Cap.
02-03Other

Director

3,997 0.0424%
24-11-25Other

Chief Executive Officer

315,421 6.6191%
24-11-25Other

Chief Financial Officer

149,533 3.1380%
Change 5-day change 1-year change 3-year change Capi.($)
+0.82%-11.74%-85.53%-96.50% 6.13M
+0.50%+0.17%+25.48%-3.50% 12.44B
+0.84%+0.36%+59.52%+29.22% 5.89B
+1.86%+3.07%+7.62%+10.17% 5.48B
-0.08%-4.11%-31.52%+12.39% 3.91B
-0.88%-5.15% - - 3.97B
+2.03%+3.37%-26.88%-24.86% 3.75B
-0.80%-0.48%+40.68%+251.31% 1.81B
+0.75%+3.71%-14.52%-64.31% 1.7B
+1.15%-0.37%+59.41%-6.01% 1.52B
Average +0.62%-2.43%+3.81%+11.99% 4.05B
Weighted average by Cap. +0.67%-0.16%+17.09%+13.02%

Financials

2026 *2027 *
Net sales 23.12M 20.31M 18.71M 17.5M 32.81M 2.18B 33.42M 225M 86.96M 1.08B 86.82M 84.92M 3.74B 34.51M 30.31M 27.93M 26.11M 48.98M 3.26B 49.88M 335M 130M 1.61B 130M 127M 5.58B
Net income -27.35M -24.02M -22.13M -20.7M -38.82M -2.58B -39.53M -266M -103M -1.27B -103M -100M -4.42B -13.85M -12.17M -11.21M -10.48M -19.66M -1.31B -20.02M -135M -52.1M -644M -52.02M -50.88M -2.24B
Net Debt - -
Logo Vivos Therapeutics, Inc.
Vivos Therapeutics, Inc. is a medical technology company focused on developing and commercializing diagnostic and treatment methods that promote sleep wellness and health for patients suffering from breathing and sleep issues such as obstructive sleep apnea (OSA) and snoring in adults. The Company's Complete Airway Repositioning and/or Expansion (CARE) devices are the oral appliances cleared by the United States Food and Drug Administration (FDA) for adult patients diagnosed with all severity levels of OSA (including severe OSA) and moderate-to-severe OSA in children ages 6 to 17 within the FDA cleared usage for such devices. The Company's products and services include Vivos CARE oral appliance therapy, Vivos oral appliances and therapies outside of CARE system, Vivos AireO2, Adjunctive Treatment, Treatment Navigator, Vivos Billing Intelligence Service (BIS) and Vivos Airway Intelligence Service, and others. The Company has sleep testing centers and associated medical sleep practice.
Employees
270
Date Price Change Volume
26-06-25 US$0.4413 -0.02% 96,396
26-06-24 US$0.4414 -5.34% 269,841
26-06-23 US$0.4663 +15.94% 984,590
26-06-22 US$0.4022 -19.56% 784,276
26-06-18 US$0.5000 -2.19% 500,604
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
0.4414USD
Average target price
2.450USD
Spread / Average Target
+455.05%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. VVOS Stock